Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

15.55
Delayed Data
As of Apr 27
 -0.95 / -5.76%
Today’s Change
15.30
Today|||52-Week Range
33.00
-17.29%
Year-to-Date
Acorda Shares Fall 5% in an Earnings Miss
Apr 27 / TheStreet.com - Paid Partner Content
Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports
Apr 27 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close16.50
Today’s open16.50
Day’s range15.30 - 16.50
Volume1,249,711
Average volume (3 months)1,027,001
Market cap$771.5M
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+489.14%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.13

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc-0.18-1.46%
HSKAHeska Corp-2.91-2.69%
MGNXMacroGenics Inc+0.07+0.32%
ACRSAclaris Therapeutics...-0.05-0.17%
Data as of 3:59pm ET, 04/27/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts